Frontlight ResearchEarly access
Trial site
The first hospital of Qiqihar
- 6running trials
- 4closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes3 trials
- Stroke2 trials
- Asthma1 trial
- COPD1 trial
- Coronary artery disease1 trial
- Lung cancer1 trial
- Rheumatoid arthritis1 trial
- Phase
- Phase 37 trials
- Phase 22 trials
- Status
- Completed3 trials
- Active, not recruiting2 trials
- Not yet recruiting2 trials
- Enrolling by invitation1 trial
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Shenzhen HighTide Biopharmaceutical Ltd.3 trials
- Akeso1 trial
- Capital Medical University1 trial
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1 trial
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.1 trial
- and 3 more
Running trials
Enrolling by invitation
Recruiting
TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection
Active, not recruiting
Recruiting
Not yet recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Asthma1 recruiting
- Coronary artery disease1 recruiting
- Lung cancer1 recruiting
- Stroke1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026